Barrett Emily S, Sullivan Alexandra, Workman Tomomi, Zhang Yuhong, Loftus Christine T, Szpiro Adam A, Paquette Alison, MacDonald James W, Coccia Michael, Smith Roger, Bowman Maria, Smith Alicia, Derefinko Karen, Nguyen Ruby H N, Zhao Qi, Sathyanarayana Sheela, Karr Catherine, LeWinn Kaja Z, Bush Nicole R
Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA; Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ, USA.
Center for Health and Community, University of California, San Francisco, CA, USA; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Psychoneuroendocrinology. 2024 May;163:106994. doi: 10.1016/j.psyneuen.2024.106994. Epub 2024 Feb 16.
Placental corticotropin-releasing hormone (pCRH) is a neuroactive peptide produced in high concentrations in mid-late pregnancy, during key periods of fetal brain development. Some evidence suggests that higher pCRH exposure during gestation is associated with adverse neurodevelopment, particularly in female offspring. In 858 mother-child dyads from the sociodemographically diverse CANDLE cohort (Memphis, TN), we examined: (1) the slope of pCRH rise in mid-late pregnancy and (2) estimated pCRH at delivery as a measure of cumulative prenatal exposure. When children were 4 years-old, mothers reported on problem behaviors using the Child Behavior Checklist (CBCL) and cognitive performance was assessed by trained psychologists using the Stanford-Binet Intelligence Scales. We fitted linear regression models examining pCRH in relation to behavioral and cognitive performance measures, adjusting for covariates. Using interaction models, we evaluated whether associations differed by fetal sex, breastfeeding, and postnatal neighborhood opportunity. In the full cohort, log-transformed pCRH measures were not associated with outcomes; however, we observed sex differences in some models (interaction p-values≤0.01). In male offspring, an interquartile (IQR) increase in pCRH slope (but not estimated pCRH at delivery), was positively associated with raw Total (β=3.06, 95%CI: 0.40, 5.72), Internalizing (β=0.89, 95%CI: 0.03, 1.76), and Externalizing (β=1.25, 95%CI: 0.27, 2.22) Problem scores, whereas, in females, all associations were negative (Total Problems: β=-1.99, 95%CI: -3.89, -0.09; Internalizing: β=-0.82, 95%CI: -1.42, -0.23; Externalizing: β=-0.56, 95%CI: -1.34, 0.22). No associations with cognitive performance were observed nor did we observe moderation by breastfeeding or postnatal neighborhood opportunity. Our results provide further evidence that prenatal pCRH exposure may impact subsequent child behavior in sex-specific ways, however in contrast to prior studies suggesting adverse impacts in females, steeper mid-gestation pCRH rise was associated with more problem behaviors in males, but fewer in females.
胎盘促肾上腺皮质激素释放激素(pCRH)是一种神经活性肽,在妊娠中后期胎儿脑发育的关键时期大量产生。一些证据表明,孕期较高的pCRH暴露与不良神经发育有关,尤其是在雌性后代中。在来自社会人口统计学多样化的CANDLE队列(田纳西州孟菲斯)的858对母婴中,我们研究了:(1)妊娠中后期pCRH上升的斜率,以及(2)分娩时估计的pCRH,作为累积产前暴露的指标。当孩子4岁时,母亲使用儿童行为检查表(CBCL)报告问题行为,训练有素的心理学家使用斯坦福-比奈智力量表评估认知表现。我们拟合了线性回归模型,研究pCRH与行为和认知表现指标的关系,并对协变量进行了调整。使用交互模型,我们评估了关联是否因胎儿性别、母乳喂养和产后邻里环境机会而有所不同。在整个队列中,对数转换后的pCRH测量值与结果无关;然而,我们在一些模型中观察到了性别差异(交互p值≤0.01)。在雄性后代中,pCRH斜率增加一个四分位数间距(IQR)(而非分娩时估计的pCRH)与原始总分(β=3.06,95%CI:0.40,5.72)、内化问题(β=0.89,95%CI:0.03,1.76)和外化问题(β=1.25,95%CI:0.27,2.22)得分呈正相关,而在雌性后代中,所有关联均为负相关(总问题:β=-1.99,95%CI:-3.89,-0.09;内化问题:β=-0.82,95%CI:-1.42,-0.23;外化问题:β=-0.56,95%CI:-1.34,0.22)。未观察到与认知表现的关联,也未观察到母乳喂养或产后邻里环境机会的调节作用。我们的结果提供了进一步的证据,表明产前pCRH暴露可能以性别特异性方式影响儿童随后的行为,然而,与之前表明对雌性有不利影响的研究相反,妊娠中期pCRH上升越陡峭,与雄性后代更多的问题行为相关,但与雌性后代较少的问题行为相关。